Resmed (RSMDF) Change in Receivables (2009 - 2026)

Resmed has reported Change in Receivables for 18 years, with the latest figure at $16.9 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Receivables fell 57.89% year-over-year to $16.9 million; the trailing twelve-month figure through Mar 2026 stood at $64.8 million (down 49.78% YoY), and the FY2025 full-year result was $76.7 million, down 42.89% from the prior year.
• Change in Receivables for Q1 2026 stood at $16.9 million, down from $72.7 million in the prior quarter.
• The five-year high for Change in Receivables was $78.8 million in Q2 2022, with the low at -$36.4 million in Q3 2024.
• Historically, Change in Receivables has averaged $25.9 million across 5 years, with a median of $19.6 million in 2022.
• The largest YoY upside for Change in Receivables was 347.27% in 2024 against a maximum downside of 457.35% in 2024.
• Resmed's Change in Receivables stood at $19.6 million in 2022, then jumped by 36.85% to $26.8 million in 2023, then soared by 153.15% to $67.9 million in 2024, then climbed by 7.12% to $72.7 million in 2025, then tumbled by 76.81% to $16.9 million in 2026.
• The last three Change in Receivables figures came in at $16.9 million (Q1 2026), $72.7 million (Q4 2025), and -$30.0 million (Q3 2025), per Business Quant data.